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ABSTRACT 
 
Background. If, when and how to treat patients with chronic ischemic mitral 
regurgitation remains at present controversial. An encouraging surgical 
approach is represented by performing under-sized mitral annuloplasty in 
most part of patients with mitral regurgitation due to annular dilation or 
papillary muscle displacement. However, the modifications at mid-term 
follow-up of the diastolic function in these patients, hasn’t been definitely 
established yet. So, in this study we focused on the functional results observed 
in patients who underwent undersized mitral annuloplasty, paying particular 
attention to diastolic function. 
Methods. We retrospectively investigated all available data from 112 patients 
affected by chronic ischemic mitral regurgitation who underwent surgical 
myocardial revascularization associated to implantation of a prosthetic 
(mitral) annular ring. Mean follow-up time was 20 ± 10 months 
Results. Mitral repair was possible in every patient, 30-day mortality was 
5.4%. The strongest associations with hospital mortality at univariate analysis 
were a poor ejection fraction (p = 0.002) and an high pulmonary pressure (p = 
0.001). At late follow-up no residual regurgitation was present in 71% of 
patients, trivial regurgitation in 24% and mild in 5%. Tenting area reduced 
from 3.4 ± 1.1 cm2 to 1.9 ± 0.5cm2 at discharge (p<0.001), and to 1.9 ± 0.5cm2 
and 1.9 ± 0.3cm2 at early and late follow-up. Systolic and diastolic sphericity 
index significantly reduced at discharge (p = 0.002 and p < 0.001, 
respectively) and at early follow-up (p < 0.001). Considering at least a 15% 
decrease of the end-systolic volume of the left ventricle as an index of left 
ventricular reverse remodelling (LVRR),  61% of the patients (n. = 64) 
showed LVRR at discharge, 78% (n. = 61) at early follow up (χ2 = 10.1, p = 
0.006) and 87.5% (n. = 79) at late follow-up (χ2 = 0.57, p = ns). Part of the 
patients recovered a normal diastolic pattern at discharge (46%), at early 
follow-up (50%) and at late follow-up (54%). 
Conclusions. Adding an undersized annular ring implantation to complete 
myocardial revascularization yields to good functional results in terms of 
freedom from mitral regurgitation recidivism, reverse left ventricular 
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remodelling, and improvement of both systolic and diastolic left ventricular 
function.  
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AIM OF THE STUDY 
 
 
The treatment of a patient affected by chronic ischemic mitral 
regurgitation (CIMR) is still controversial for diagnostic techniques, 
indications to therapy and choice of surgical technique. 
A very encouraging surgical approach is represented by the 
implantation of an undersized mitral prosthetic ring. This would be able to 
solve most part of CIMR secondary to annular dilation and/or displacement of 
the papillary muscle/s. However, the real efficacy of such an option is at 
present a much debated question because the effects in terms of ventricular 
response to mitral repair and clinical consequences are not well known. An 
important paragraph in this kind of patients, at present really very few 
investigated, is represented by the modifications of diastolic function both 
immediately and at longer follow-up. 
In the present paper we searched for functional results obtained in an 
unselected group of patients with at least moderate CIMR who underwent a 
combined operation of complete myocardial revascularization and under-sized 
annuloplasty. In particular we studied: mitral regurgitation recidivism, mitral 
valve deformation, global remodelling, local remodelling and reverse 
remodelling of the left ventricle, and the mid-term follow-up function of the 
left ventricle. 
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INTRODUCTION 
 
Ischemic mitral regurgitation: definition 
A patient with previous myocardial infarction can develop mitral 
regurgitation that can be defined “ischemic” as a consequence of ventricular 
remodelling 1. This condition is clearly separate from “organic” mitral 
regurgitation (secondary to rheumatic disease, valve degeneration, post-
endocarditic regurgitation …). The classification of the mitral regurgitation 
proposed by Carpentier 2 is very useful to better understand CIMR and is 
based on aetiology, valvular lesions and consequent valvular dysfunction. 
This classification bases on opening and closing movements of the mitral 
leaflets (Fig. 1). In type I dysfunction there’s normal motion of the leaflets 
and the cause of the regurgitation is the annular dilatation. In type II 
dysfunction the excessive motion (prolapse) causes the regurgitation mostly 
secondary to lengthening and/or rupture of a chorda tendinea or a papillary 
muscle. In type III dysfunction the restricted motion leads to the lost of leaflet 
coaptation. In the type IIIa dysfunction motion is restricted both in systole and 
in diastole, and major causes are leaflet retraction, chordal shortening and 
fusion, and commissural fusion. In the type IIIb dysfunction the motion is 
restricted only in systole and the mechanism of this consists in dilation and 
dysfunction of the left ventricle with displacement of the papillary muscles. 
Ischemic mitral regurgitation can be consequence of a type I, II or IIIb lesion 
(Tab. I). In type I dysfunction the annular dilation can be secondary to a basal 
infarction or to a progressive enlargement of the left ventricular chamber. In 
type II dysfunction the regurgitation is secondary to acute ischemic rupture of 
a papillary muscle 3. In type IIIb dysfunction (most frequent form of ischemic 
mitral regurgitation) we have more components: left ventricle modifications 
(wall motion abnormal condition, dilation, increased sphericity), sub-valvular 
modifications (papillary muscles displacement and leaflet tethering), and 
annular modifications (dilatation and distortion) 1.  
Type IIIb mitral regurgitation is defined by: 1) symptomatic multivasal 
coronaropathy, with or without previous myocardial infarction; 2) mitral 
regurgitation ≥ 2+ at echocardiogram or angio-ventriculogram; 3) normal 
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mitral leaflets; 4) absence of  stenosis.  It can be defined as “functional” 
relatively to the integrity of the mitral valve. 
In the present paper we refer to “chronic” ischemic mitral regurgitation, 
excluding the acute II type due to papillary rupture because the implications 
of the acute onset of this condition would lead out of the target of this study. 
 
Clinical impact of ischemic mitral regurgitation 
The interest on CIMR is related to negative impact it have on mid-term 
and late survival of patients with coronary disease. In patients with 
myocardial infarction, mild mitral regurgitation represents and independent 
risk factor for 1-year mortality 4-6. Grigioni demonstrated, in well matched 
patients, the important prognostic value of the presence or the worsening of 
CIMR: Effective Regurgitant Orifice (ERO) > 20 mm2 are directly and 
independently associated to higher mortality (Fig. 2). Therefore, the 
assessment of the mitral regurgitation is basic not only during the acute and 
soon post-infarctual phase, but also in the chronic phase in order to stratify the 
risk of death. Adler et al. 7, observed a double risk of late death when mitral 
regurgitation was not fixed in a wide population of more than 2000 patients.  
It seems obvious that the suppression of the regurgitation could 
represent a goal of the treatment of the patient with cardiac failure. This goal 
can be reached pursued both medically (reducing pre- ad afterload) and 
surgically.  
 
Mitral valve anatomy 
The mitral valve apparatus consists of 6 elements: posterior wall of the 
left atrium, annulus, leaflets, chordae, papillary muscles, and left ventricular 
free wall. Integrity and interdependency of all of these elements causes 
normal coaptation. The appearance of mitral regurgitation into a dilated and 
hypo-kinetic left ventricle requires, in absence of valvular lesions, the 
abnormal function of at least another component of the mitral  apparatus.  
Doppler echocardiography has been previously used to demonstrate that 
the incomplete coaptation of the mitral leaflets causes the mitral regurgitation. 
Being the amount of the area of the mitral leaflet about double the orifice 
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area, functional abnormalities have been hypothesised to interpret the 
regurgitation.  
 
Leaflets 
Anatomically, mitral valve is monocuspid, the leaflet is continuous 
along the annular circumference. Nevertheless, surgically (and commonly) 
commissures separate and anterior leaflet (or aortic leaflet) from a posterior or 
mural leaflet. The anterior leaflet takes about 1/3 of the annulus, the posterior 
leaflet 2/3.  The posterior leaflet is subdivisible (by secondary commissures) 
into 3 scallops: lateral (P1), central ( P2), and medial (P3).  Surgical strategies 
can vary accordingly to the different scallop prolapsing. The anterior leaflet is 
also subdivisible in 3 parts: A1, A2, A3 corresponding to the posterior scallop 
(Fig. 3).  The 2 leaflets face each other along an “apposition zone” (from the 
free edge of the leaflet a few millimetres toward the body of the leaflet). The 
leaflet coaptation along the apposition zone reduces the pressure across the 
valve during the systole because it acts simultaneously onto the facing 
portions of the leaflet, cancelling each other out.  
 
Papillary muscles 
A normal kinetics and sequence of contraction of the papillary muscles 
(PMs) is basic for a optimal valve competence. The contraction of PMs 
follows the developing of endoventricular pressure, their maximal shortening 
is reached during the opening period and continues throughout the entire 
period of isovolumetric relaxing, and the maximal lengthening is reached 
during the closing period. Contrary to past beliefs, isolate dysfunction of a 
PM is not sufficient to give mitral regurgitation in patients with ischemic left 
ventricular dysfunction.  
Indeed in 1968 Burch et al. 8 advocated the so called “papillary muscle 
syndrome” where a reduced or absent systolic shortening of the ischemic PM 
could give mitral regurgitation by leaflet prolapse. Subsequent studies have 
demonstrated how leaflet prolapse is relatively rare in patients with ischemic 
mitral regurgitation. Mittal et al. 9 observed that the ischemic damage of both 
PMs and contiguous ventricular wall could give mitral regurgitation, but not 
the ischemic damage of one PM.  
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Kaul et al. 10 experimentally showed the relation between functional 
mitral regurgitation and alteration of one of the papillary muscle, both in 
presence of regional and global left ventricular dysfunction. A single PM 
dysfunction (with its adjacent portion of free wall) in presence of global good 
contractility couldn’t give mitral regurgitation. Global reduction of left 
ventricular function seems necessary for the development of mitral 
regurgitation, and the severity of it is proportional to the degree of cardiac 
failure.  This author 11 reported a strict correlation between the distance of the 
point of coaptation of the mitral leaflets from the mitral annulus plane and the 
degree of mitral regurgitation. Indeed, the symmetric or asymmetric 
misalignment of the papillary muscles (PMs), and the consequent increase of 
the traction force exerted by the chordae (under the tension originated from 
the ventricular wall) on the valve may cause incomplete closure of the mitral 
leaflets. Such misalignment would be consequence of the left ventricular 
remodelling, both regional and global, causing displacement of the base of the 
PMs postero-laterally and apically, that is outward and inferiorly  the mitral 
orifice (Fig. 4 and 5).  
 
Mitral annulus 
The mitral annulus is the scaffolding of the valve. It’s a fibrous 
ellipsoidal structure with a shorter septum-lateral diameter and a longer inter-
commissural diameter. The antero-medial portion of the annulus gives 
insertion to the anterior leaflet and it’s non well anatomically distinguished. 
It’s part of the fibrous continuity that takes part between the non coronary and 
the left coronary cusp of the aortic root and it’s delimited anteriorly and 
posteriorly by 2 fibrous trigones. The postero-lateral portion of the annulus is 
instead a fibrous ring that separates atrial myocardium from ventricular 
myocardium. This anatomical connection (annulus-myocardium) causes a 
sphyncteric action in systole capable to approximate the leaflets so reducing 
the annular area of about 25%, supporting valve closure. 
Three-dimensional echocardiography has shown an important 
relationship between the aortic root and the mitral annulus. Kaplan et al. 12 
have demonstrated that because the aortic root leans on the hollow portion of 
the annulus, during systole the flow through the aorta dilates it and press the 
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annulus causing a decrease of the septum-lateral diameter and supporting 
leaflet coaptation. This mechanism is however incomplete in patients with 
dilated cardiomyopathy where the septum-lateral diameter  increases and the 
aortic dilation is reduced by the low cardiac output. The mitral annulus 
changes its shape and diameter during systole. The annular diameter strictly 
correlates to the size of the left ventricular chamber and in particular to the 
end-diastolic volume. Authors have considered the dilatation of the mitral 
annulus a main cause of genesis and maintenance of the functional mitral 
regurgitation in patients with left heart failure 13,14.  Boltwood 13 compared 
annular area and circumference of healthy people to measures obtained from 
patients with dilated cardiomyopathy (with or without mitral regurgitation). 
The group of patients with mitral regurgitation presented greater annular 
dimensions than both healthy subjects and patients without mitral 
regurgitation. Studying a variety of parameters they found that annular 
dilatation represented the main determinant of the functional mitral 
regurgitation. However the sole annular dilation shouldn’t be capable to 
effectively reduce the closing surface of the leaflets. Otsuji et al. 15 recently 
compared the echocardiographic dimensions of the mitral annulus in patients 
with lone atrial fibrillation (with no ventricular dilation nor dysfunction) to 
those obtained in patients with idiopathic or post-ischemic cardiomyopathy. 
Under the same annular diameter patients with lone atrial fibrillation showed 
a milder degree of mitral regurgitation in confront of the dilated patients who 
presented  more moderate-to-severe degrees of mitral regurgitation. They 
concluded that functional mitral regurgitation needs both annular dilatation 
consistent with dilated and dysfunctional left ventricle. This would cause an 
altered balance of forces acting to the mitral leaflets. The pathophysiologic 
assumption of the treatment of the functional mitral regurgitation in patients 
with dilated cardiomyopathy is represented by the reduction of the annular 
diameter. Nevertheless such an intervention, in the absence of a reduction of 
the left ventricular size could be not enough to resolve regurgitation and, as a 
consequence, to improve late-term prognosis 16,17. 
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Ventricular geometry 
It’s been demonstrated that  under the same left ventricular dilation and 
dysfunction (volumes and ejection fraction), mitral regurgitation is present in 
those ventricles that reshape loosing the physiologic ellipsoidal shape toward 
a more spherical morphology 18. The sphericity index (SI = left ventricular 
transverse diameter/ longitudinal diameter, in systole and in diastole) has been 
calculated to better quantify the deformation of the left ventricle. When SI is 1 
the shape is spherical. Otsuji 15 created an in vivo pharmacological model of 
left ventricular dysfunction where the integrity of the pericardium didn’t let 
the ventricle dilate. Evaluation of mitral regurgitation was achieved by means 
of 3D-echocardiography measuring spatial relations between the tips of the 
PMs and the mitral leaflets. They demonstrated that in presence of sever left 
ventricular dysfunction, in absence of dilatation (pericardium integral) mitral 
regurgitation was not significant whilst in presence of dilatation (pericardium 
opened) mitral regurgitation associated was moderate. The 3D reconstruction 
shoed how the regurgitant volume and the area of the orifice didn’t correlate 
with ejection fraction (i.e. contractility) but with the increased distance 
between the PM and the anterior portion of the annulus. 
Mitral regurgitation can be explained in terms of altered balance 
between the forces acting on the leaflets during the systole. It has been in fact  
observed that the incomplete systolic closure of the mitral leaflets results 
from: geometrical deformation of the left ventricle combined with the 
displacement of PMs with consequent leaflet tethering and decrease of the 
closing force secondary to the contractile failure (Fig. 6). There would be a 
shift of the coaptation point toward the left ventricular apex causing a 
limitation of the closing motion during systole (leaflet tenting) 10. In theory, 
being the mass of the leaflet quite little they shouldn’t need much force for 
closure although in presence of left ventricular dysfunction. Nevertheless 
Otsuji 15 proposed that in presence of left ventricular dilation/dysfunction a 
modified geometry of the mitral apparatus would request a great increase of 
the closing forces. Yiu et al. 19 measured in patients with different type of 
regional remodelling different effective regurgitant orifice (ERO). They 
reported a strong relationship between a postero-apical displacement of PMs 
and greater EROs, a weaker relationship with a lateral shift. In conclusion the 
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major determinant of the ERO seems to be the systolic tenting area under the 
deformed mitral leaflets and the plane of the mitral annulus.  
 
Regurgitant orifice area and trans-mitral pressure 
The idea of regurgitant orifice was first introduced by Gorlin and Dexter 
in 1952 20 as a quantitative method of measure of mitral regurgitation, whose 
computation was achieved by hydraulics assumptions considering the orifice 
as fast during the entire cardiac cycle. It was later demonstrated that this 
parameter changes dynamically as a consequence o loading and size  
modifications of the left ventricle and the mitral annulus 21. Moreover it’s 
been recently demonstrated that the temporal pattern o the trans-mitral flow 
varies with the aetiology of the valve disease. In patients with rheumatic 
disease the orifice area is constant. In patients with degenerative disease and 
prolapse the orifice increases during mid- and end-systole 22. In patients with 
functional mitral regurgitation we can notice an increase of the orifice area in 
proto- and in end-systole, with a reduction in meso-systole. Therapeutic tools 
could be able to support or prolong the intermediate period of reduction of the 
regurgitant orifice. 
This temporal pattern can be explained as follows: 
• The regurgitant orifice area changes accordingly to the annular area 
that reduces in mid-systole and re-increases in end-systole as a 
consequence of atrial filling. 
• The regurgitant orifice area changes as a consequence of cyclic 
variations of the trans-mitral pressure, acting as a pro-coapting force 
with its peak in mid-systole. 
Studies have so been designed to investigate the role of the temporal 
variations of annulus and trans-mitral pressure into the genesis of the dynamic 
change of the regurgitant orifice area. He et al. 14 invented an in vitro model 
of a mitral apparatus that mimicking a ventricular failure showed a flow 
pattern of the functional mitral regurgitation characterised by a main proto– 
and end-systole, with a reduction in mid-systole consistent with the peak of 
trans-mitral pressure. The contractile dysfunction and the increase of the left 
atrial pressure causes a decrease of the trans-mitral pressure. The increased 
tension of the mitral leaflets due to the apical displacement of the PMs delays 
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the valve closure, but in mid-systole, the greatest endo-ventricular pressure 
produces a force strong enough to reduce the dimensions of the regurgitant 
orifice that re-dilates at the end of systole (Fig. 7).  
Hung et al.16, estimating with the PISA method (see later) the regurgitant 
volume, have studied an interesting group of patients with low ejection 
fraction and functional mitral regurgitation some of them already operated on 
by positioning of a Carpentier-Edwards PhysioRing in order to evaluate the 
temporal pattern of the regurgitant area in presence of a fast annulus. 
Notwithstanding the relevance of both factors for the dynamic variation of the 
regurgitant area, the trans-mitral pressure is the major determinant of the 
functional mitral regurgitation in comparison with annular area. 
The regurgitant orifice area presents cyclic variation specular to those of 
trans-mitral  pressure also in patients with fixed annulus. A plot describing 
regurgitant orifice for systole duration shows, in patients with left ventricular 
dysfunction and apical-posterolateral displacement of the PMs with annular 
dilatation a bi-modal pattern of the regurgitant orifice area, with decrease in 
mid-systole. Therefore, in presence of systolic dysfunction without dilation 
and deformation of the left ventricle, the sole reduction of the closing force 
cannot cause an appreciable mitral regurgitation. The combination of an 
altered wall kinetics with an increased sphericity causes incomplete 
coaptation and the generation of an effective regurgitant orifice (ERO), whose 
wideness strictly correlates with the severity of the mitral regurgitation. The 
strict inter-dependence between the ERO and the trans-mitral pressure gives 
reason to argue the presence, in dilated left ventricles, of forces that oppose to 
valve leaflet closure (tethering forces), Fig. 8 - A.     
The systolic tethering of the mitral leaflets delays the coaptation till the left 
intra-ventricular pressure increases enough to close the valve. The delayed 
closure reveals a left ventricular dysfunction that hampers the developing of 
the intra-cavity pressure. We must consider the functional mitral regurgitation 
a dynamic lesion. The dimensions of the orifice and the regurgitant volume 
can considerably vary as a consequence of therapeutic tools capable to reduce 
the left ventricular dimensions, to produce a reverse remodelling towards an 
ellipsoidal shape, or to modify the atrio-ventricular pressure gradient. It’s 
possible to under-estimate the entity of the regurgitation during the pre-
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operative assessment, especially during the trans-oesophageal 
echocardiography made intra-operatively due to hemodynamic changes of 
pre- and after-load during general anaesthesia 23. 
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Echocardiographic evaluation of the functional mitral regurgitation 
 
Mono-bidimensional echocardiography 
The echocardiographic examination, mono-, bidimensional, and 
Doppler, is the most used technique to evaluate the functional mitral 
regurgitation. This relatively cheap diagnostic tool makes it clear most part of 
pathophysiologic mechanisms at the base of this disease. Many methods have 
been described in the world literature each of them addressing the estimation 
of the severity of the regurgitation. None of them, alone, is probably reliable. 
Indeed using a pool of methods based upon different theoretical assumptions 
makes it possible to apply a step-by-step strategy of evaluation and 
comparison: the greater the coherence between them, the greater the reliability 
of the evaluation. The functional mitral regurgitation has a single flow pattern, 
with an proto-systolic increase and a reduction in end-systole. 2-D 
echocardiography allows the calculation of a lot of parameters and a 
morphologic evaluation: 
1. Lost of coaptation of the mitral leaflets. 
2. Tenting area of the mitral valve (a triangular area whose base is the 
annular plane and the height is the distance between the point of 
coaptation of the leaflet in proto- and end-systole). This measure tells us 
the entity of the displacement of the coaptation point toward the 
ventricular apex (Fig. 8 – B).  
3. Mitral annular diameter, from whom it’s possible to deduce the annular 
area using an ellipsoidal assumption (d1xd2xpi/4) where d1 and d2 are the 
distances between the point of insertion of the mitral leaflets to the 
annulus measured in the apical 4 chambers and 2 chambers views. 
4. Dys-alignment of the papillary muscles, measuring the distance between 
the papillary muscles from the short-axis para-sternal view and the 
distance between the apex of the PM and the point of insertion to the 
annulus of the contra-lateral mitral leaflet, both in apical 4 chambers and 2 
chambers view (Fig. 9). 
5. Sphericity Index: calculated as the ratio between the transverse and the 
longitudinal diameters both from the long-axis para-sternal view and in 
short axis, in end-systole. 
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In order to estimate the severity of the mitral regurgitation, the non-invasive 
determination with echo-colour-Doppler has widely shown a good correlation 
with the data obtained by ventriculography. A variety of methods, both 
qualitative and quantitative have been developed to assess the degree 
(severity) of the regurgitation. The echocardiographic gold standard method 
(accurate, routine-usable, clinical-correlated) however seems to be far. 
 
Quantitative methods 
Quantitative measures include: regurgitant volume, regurgitant fraction, 
effective regurgitant orifice (ERO), obtained with bidimensional and Doppler 
echocardiography and with the measurement of the proximal isovelocity 
surface area (PISA), and the vena contracta (VC). The regurgitant volume is 
calculated by the assumption that the stroke-volume (SV) through an orifice is 
given by the product of the area of the orifice (pir2) by the corresponding 
velocity-time integral (VTI) at pulsed-Doppler; in absence of regurgitation, 
the SVs calculated in different region (left ventricle outflow tract, mitral, 
pulmonary valves) are equal. In presence of valvular regurgitation, the flow 
through this valve is greater than the flow of another region: the difference 
between the two SVs represents the regurgitant volume (RV) 24. In mitral 
regurgitation, the regurgitant volume is calculated as the difference between 
trans-mitral flow and trans-aortic flow (measured at the aortic outflow tract); 
from this it can be calculated the regurgitant fraction ( RF) 24: 
 
RV=SVregurg valv-SVcomp valv 
RF= (SVregurg valv-SVcomp valv)/ SVregurg valv 
 
ERO area is obtained dividing the RV by the velocity-time integral of the 
continuous Doppler flow profile of the regurgitant mitral jet 24:  
 
ERO=RV/VTI regurg jet 
 
The PISA analysis, bases upon the observation that closed to the regurgitant 
orifice the flow produces concentric surfaces of isovelocity, having 
decreasing extension and progressively increasing velocities. By the principle 
 16 
of conservation of the mass, the flow through each layer must pass through 
the regurgitant orifice. Thanks to the Doppler colour mapping it’s possible to 
identify the different layers by a selected velocity, or differently to create a 
profile of the isovelocity range as a digital map. Because of the hemispheric 
shape of the surfaces of isovelocity, the flow through each of them is equal to 
to its area (2pir² where r is the ray of the PISA) multiplied by the velocity that 
identifies that layer, defined as velocity of aliasing 24: 
 
Regurgitant flow=2pir²x Va 
  
The ERO is then measured as the ratio between the regurgitant flow and the 
peak velocity of the regurgitation obtained by continuous Doppler 24: 
 
ERO= regurgitant flow/V peak of regurgitant jet 
 
The Vena Contracta (VC) is defined as the most narrow portion of the 
regurgitant jet, localised downstream the orifice. VS is characterised by a 
laminar flow with high velocity and is a few more narrow of the anatomical 
regurgitant orifice 24. The area of the transverse section of the VC represents a 
measure of ERO. But in dynamic lesions the VC can change with 
hemodynamic conditions or during the cardiac cycle.  
 
                                     
Semi-quantitative methods 
Qualitative, or semi-quantitative analysis is based on a lot of variables 
such as colourimetrical characteristics of the regurgitant jet, the wideness of 
jet and the area (derived by colour-Doppler application), jet intensity (by 
continuous-Doppler), and the flow pattern into the pulmonary veins (obtained 
with the pulsed Doppler). The flow mapping of the regurgitant jet with colour 
Doppler analysis by different projections, makes it possible to three-
dimensionally reconstruct the wideness of the turbulence of the flow. This 
approach however deserves a specification: the turbulence pointed out into the 
left atrium by colour-Doppler is not the regurgitant volume, rather being the 
chromatic representation of the direction of flow (and consequently of the red 
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cells), of its velocity, with a different colour brilliance, and of type of flow, 
laminar or turbulent (the latter represented by a “mosaic effect”. Therefore no 
feature of the jet is directly correlated with the severity of the mitral 
regurgitation: in fact if just few red cells regurgitate through the orifice at very 
high velocity, they will determine a large area of turbulence, though a 
negligible effective regurgitant volume. Despite this theoretic limitation it’s 
been demonstrated that in most cases the greater the regurgitant volume the 
greater the area of turbulence into the left atrium 22. On this basis the 
regurgitation can be estimated by a discrete scale depicting severity from 0 to 
4 +, where 1+ means mild, 2-3+ moderate and 4+ severe degree of 
regurgitation. 
Shape and direction of the regurgitant jet depend on the geometry of the 
regurgitant orifice and therefore on the aetiology of mitral regurgitation. It’s 
been widely observed that patients with left ventricular and mitral annular 
dilation have a central and symmetric regurgitant jet. Another evaluation of 
the jet  is based on the measurement of its length  and area, expressed as a 
fraction of the area of the left atrium; however the measurement of the area by 
colour-Doppler, even so very sensible (about 90%) and specific (almost 
100%) and well-correlated to the degree of regurgitation at the angiogram, 
can be influenced by a lot of physical, geometrical, instrumental and operator-
depending factors all of them limiting its accuracy. The length of the jet 
depends on the pressure gradient between left atrium and ventricle, that is 
related to the compliance of he chambers: the grater the gradient the longer 
the jet. If left atrium pressure is high, jet length and area can result reduced 
also in presence of a great regurgitant orifice; moreover, in presence of  
atriomegalia the fraction area of left atrium taken by the jet could appear 
relatively small. It’s been demonstrated indeed that a regurgitant jet area into 
the left atrium >8 cm2, classically considered index of severe mitral 
regurgitation, can coincide with relatively small regurgitant volumes and/or 
fractions, actually over-estimating the severity of regurgitation really in 
patients affected by functional mitral regurgitation 25. 
The analysis of the flow-pattern into the pulmonary veins with pulsed-
Doppler, represents an useful index  of severity of the regurgitation. When 
regurgitant flow enters the left atrium part of the blood already into the 
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chamber necessarily shifts, and it’s been observed that in presence of severe 
mitral regurgitation an inversion of the systolic flow into the pulmonary veins 
is present. However false negatives are possible in presence of important left 
atriomegalia and atrial compliance, that make it possible the entire volume of 
regurgitant blood be accepted by left atrium without flow-reverse. And false 
positives are also possible in presence of an eccentric jet whose direction is 
oriented toward a pulmonary vein, with a consequent flow-reverse although in 
absence of a severe regurgitation. 
Taking advantage of pulsed-Doppler examination it is possible to take a 
map of the mitral regurgitation: by positioning of the sample volume into the 
atrium of mitral valve it is possible to obtain information about presence an 
length of regurgitation. By continuous-Doppler furthermore we can obtain a 
lot of information: first, being the intensity of the received signal proportional 
to the number of red cells, it’s possible to compare intensity produced by the 
regurgitant flow with that of antegrade mitral flow. By this it’s possible to 
estimate severity of mitral regurgitation24. Besides, increasing antegrade flow 
velocity through mitral valve, the more severe the regurgitation, the greater 
the antegrade velocity obtained by continous-Doppler24.  
Accordingly with ASE/ESC guidelines of 200324, parameters used to 
quantify mitral regurgitation are reported in Tab. II. 
 
 
 
Role of trans-oesophageal echocardiography 
 
Trans-oesophageal echocardiography (TEE) plays an important role in 
determination of aetiology and severity of mitral regurgitation 26. Such 
approach gives greater accuracy than trans-thoracic (p<0,001) both in patients 
with good and poor acoustic window, to more precisely research anatomical 
details (in particular leaflet details) 27. During the last years, as a consequence 
of growing interest into mitral sparing procedures, intra-operative TEE is 
playing an important role in all patients with coronary artery disease and some 
a degree of mitral regurgitation, undergoing coronary artery bypass grafting 
operations. This because by TEE it’s possible to display the presence of an 
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entire set of anatomical features/alterations like chordal rupture, leaflet flail 
and so on, supporting the surgeon to decide surgical strategy. 
It’s been however observed that intra-operatively patients with 
functional mitral regurgitation can be underestimated 28. Hemodynamic 
effects of anaesthetics (by reducing afterload) can reduce severity of mitral 
regurgitation 23. Underestimation and decision to not correct mitral 
regurgitation can lead to worst prognosis: a retrospective analysis assembling 
more than 2000 patients operated on with only CABG demonstrated how not 
corrected mitral regurgitation correlated to doubled risk of late death 7. 
Moreover, an adding risk of about 10% is calculated when delayed mitral 
surgery is performed. 
 
Surgical techniques for the treatment of chronic ischemic mitral 
regurgitation 
 
Surgery for mitral regurgitation is based on valve replacement and 
repair. In this chapter it will not further report about replacement. During the 
last years some wall-stress reducing procedures have been celebrated. These 
techniques act on some determinants of the geometrical alterations of the left 
ventricle, in particular on the radius of the minor diameter of the left ventricle. 
Bolling et al. 29 proposed and alternative approach in patients with 
cardiomyopathy complicated by functional mitral regurgitation: undersized 
annuloplasty. A smaller ring, remodelling the base of the heart, would reduce 
left ventricular wall-stress and re-establish an elliptical shape to the chamber 
29
. In a paper from Tibayan et al. 30 undersizing annuloplasty not only reduced 
global sphericity but also the end-systolic bend radius of left ventricle (an 
important determinant of wall-stress). This important effect involved not only 
the base (as before assumable) but also the equatorial and apical portions of 
the left ventricle. Correction of leaflet tethering is achieved in most patient by 
annuloplasty alone, nevertheless in some other surgical steps are necessary. 
These are represented by so called “edge-to-edge” suture between the leaflets, 
both in the central part of the leaflet (symmetric displacement) and closed to 
the (posterior) commissure (asymmetric displacement); shortening of 
secondary chordae to favour mobilisation of the anterior leaflet and its 
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coaptation with the posterior one; leaflet extension; wall resection, plication 
and remodelling; PM repositioning all represent very complex manoeuvres 
that can be added in order to achieve good valve competence. 
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METHODS 
 
 
Population 
 
Data of all patients who underwent combined myocardial 
revascularization (CABG)  and mitral annuloplasty in our cardiac surgery unit 
(SOD Cardiochirurgia – Dipartimento del cuore e dei vasi – Direttore Dott. P. 
Stefàno) since September 2001 to September 2004 have been retrospectively 
analysed and integrated with prospective follow-up for most of them.  
Selection of patients was based on the following items: 
• Presence of moderate to severe mitral regurgitation 
• Previous myocardial infarction (more than 2 weeks)  
• More than 75% stenosis of one or more coronary arteries with 
corresponding asynergic area 
• Absence of mitral regurgitation due to organic mitral disease. 
Exclusion criteria were: 
• Post-ischemic rupture of a papillary muscle or chorda tendinea 
• Accompanying congenital cardiac disease 
• Presence of other valve disease 
• Presence of atrial fibrillation or cardiac frequency more than 100 bpm 
(because possibly related to another cause of mitral regurgitation)  
• Previous ventriculoplasty 
A total of 112 patients has been enrolled whose preoperative 
characteristics are presented in Tab. III. Sixty-eight were male and 44 female, 
mean age was 68 ± 10 years with a range between 37 and 88 years. Mean 
functional class (expressed accordingly to the classification of heart failure 
proposed by the New York Heart Association) was 3.4 ± 0.4. Expressing 
mitral regurgitation on a semi-qualitative scale between 1 and 4, mean 
regurgitation was 3.3 ± 0.5. Each patient was affected by multivessel coronary 
disease. 
It was proposed to discharged patients to adhere to a follow-up program 
(clinical and echocardiographic) spliced into three main moments: discharge, 
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early follow-up and late follow-up. Data of discharge have been collected by 
means of the unit database, containing clinical and echocardiographical data. 
For patients who presented echocardiographic examination already performed 
into an external medical facility in a period of time corresponding to our early 
and/or late follow up, completeness and accuracy of data was tested. If quality 
was acceptable, the external echocardiography was included, on the contrary 
further internal examination was performed in all patients with sub-optimal 
echocardiography. This way the major number of examinations have been 
collected. Clinical data have been mostly collected by case history and direct 
examination of the patient. For most patients with good external 
echocardiographic data, clinical information was gathered by phone contact 
and report from own cardiology.  
They were eventually characterised three periods: discharge, early 
follow-up (between 1 and 6 months, mean 4 ± 1.9 months) and late follow-up 
, between 8 and 40 months (mean 20 ± 10.4 months). 
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Echocardiographic measurements 
 
Every patient underwent trans-thoracic echocardiography (TTE) and 
trans-oesophageal peri-operative echocardiography (TEE) and TTE at 
discharge and other follow-up. All the peri-operative examination and most of 
follow-up echocardiograms were performed using Acuson Sequoia with a  3.5 
MHz transducer (Acuson Corporation, Mountain View, CA). Standard 
projections defined by ASE/ESC 24 have been used: long-axis and short axis 
para-sternal, apical 2-4-5 chambers for TTE. Every measurement have been 
evaluated onto at least 3 cardiac cycles.  
 
 
M-mode and B-mode  echocardiographic parameters:  
 
The measurements of end-systolic and end-diastolic transverse diameter 
of the left ventricle and diameters of left atrium have been obtained by long- 
axis para-sternal M-mode projection. End-diastolic and end-systolic volumes 
of the left ventricle, and left ventricular ejection fraction have been measured  
in apical 4-chamber projection using modified Simpson’ method and area-
length method 31. A more than 15% decrease of end-systolic left ventricular 
volume compared with preoperative values was considered a index of reverse 
remodelling of the left ventricle 32. The sphericity index (SI) was calculated as 
the ration between longitudinal and transverse diameter both in systole and in 
diastole. The closest is SI to 1, the greatest the spherical remodelling of the 
left ventricle 18. End-systolic wall stress was calculated on the base of arterial 
pressure 33. Mitral tenting area (TA) is an index of systolic deformation of the 
leaflets and can be defined as the triangular area whose base corresponds to 
the plane of the annulus and the height is the distance between the point of 
leaflet coaptation and the annular plane in proto- and end-systole, measured 
by para-sternal long-axis view. The systolic shift of the point of coaptation of 
mitral leaflets was expressed by difference between systolic and diastolic 
distance between the point of coaptation and the left ventricular apex 19,13. 
Systolic and diastolic mitral area has been deduced by measurement of 
diastolic mitral annulus (at greatest opening of the leaflets) and systolic one 
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(at closure) by 4-chambers and 2-chambers apical view 34. Regional wall 
kinetics has been described by means of “wall motion index” (WMI) with 17 
segments 35. To quantify kinetics a score from 1 to 4 has been used being 1 = 
normo-kinetic, 2 = hypo-kinetic, 3 = a-kinetic, 4 = dys-kinetic area. The ratio 
between the sum of the scores of the segments and the number of the total 
number of analysed segments is the WMI. It can vary form 1, no regional a-
synergy, to 3 35. PMs displacement has been directly measured by the distance 
between PMs (para-sternal short-axis view), or by means of the distance 
between the head of the PM and the insertion of the contra-lateral leaflet to 
the mitral annulus, both by apical 4-chambers ad by apical 2 –chambers view. 
By apical 5-chambers view, apical displacement of the posterior PM has been 
measured as the distance between the head of the PM and the inter-valvular 
mitro-aortic fibrosa 19.    
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Evaluation of the mitral regurgitation 
 
Parameters of quantitative evaluation 
 
Doppler method of volumes:   
stroke-volume (SV) through and orifice is given by the product of the 
area of the orifice (pir2)  by the correspondent velocity-time integral (VTI) at 
pulsed Doppler; in absence of regurgitation SVs from different spots (left 
ventricular outflow tract, mitral, pulmonary) are equal. In presence of a 
valvular regurgitation the flow across that valve is greater than across another 
spot: the difference between the 2 SV represents the Regurgitant Volume 
(RV) 24. 
For mitral regurgitation RV is calculated as the difference between the 
mitral output and the aortic output; it’s then possible calculate the Regurgitant 
Fraction (RF) 24: 
 
RV=SVregurg valv-SVcomp valv 
RF= (SVregurg valv-SVcomp valv)/ SVregurg valv 
 
The area of effective regurgitant orifice (ERO) was obtained dividing 
the RV by the velocity-time integral of the flow profile of the mitral jet at 
continuous-Doppler 24:  
 
ERO=RV/VTI reg jet 
 
PISA method ( proximal isovelocity surface area): 
based upon the analysis of the proximal flow of convergence. The 
regurgitant flow is calculated by means of the formula 2pi x r 2 x Va where r is 
the radius of the PISA (the distance expressed in mm between the point of 
aliasing of the flow of convergence and the mitral valve plane) and Va is the 
velocity of aliasing of the colour scale for the sending away flow 24.  In this 
case ERO can be calculated as the ratio between the regurgitant flow and the 
peak velocity of the regurgitant flow: 
 
 26 
ERO= Regurgitant flow/peak velocity (of the regurgitant flow) 24 
 
Accordingly with ASE/ESC 24 guidelines, mitral regurgitation has been 
classified in mild, moderate and severe for values of RV respectively < 30 ml, 
30-59 ml, and ≥ 60 ml/beat, for RF < 30%, 30-49% and ≥50%  ad for a value 
of ERO area < 20 mm2, 20-39 mm2 and ≥ 40 mm2.  
For patients with trivial mitral regurgitation at colour-Doppler 
examination ERO has been considered as null. 
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Evaluation of the diastolic function 
 
The diastole has been evaluated by measurement  of the trans-mitral 
flow. By pulsed-Doppler it’s possible to obtain the peak velocity of the E and 
A waves, E/A ratio, and deceleration time of the E wave 36. 
Isovolumetric relaxation time (IVRT) is obtained by continuous-Doppler with 
sample volume positioned anteriorly and medially to mitral valve toward the 
left ventricular outflow tract by apical 5-chabers view. It’s possible to 
discriminate 3 patterns that describe an alteration of the diastolic function: 
• Altered relaxation: defined by E/A ratio < 1, DT > 220 msec, and IVRT > 
100 msec; 
• Pseudo-normal pattern: defined by E/A ratio between 1 and 2, DT 
between 150 and 220 msec, and IVRT between 60-100 msec; 
• Restrictive pattern: defined by E/A ratio > 2, DT < 150 msec, and IVRT < 
60 msec 37. 
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Surgical procedure 
 
The trans-oesophageal probe was positioned in every patient after oro-
tracheal intubation, before surgical draping. The echo examination was then 
performed during different hemodynamic conditions to better state entity, 
anatomy, variations and surgical peculiarities in order to achieve a good 
repair. 
For patients with left ventricular ejection fraction < 25-30%, complex 
coronary artery disease and absence of severe peripheral vascular disease 
intra-aortic balloon pump was used peri-operatively as a prophylactic 
measure. In those patients a 40cc counter-pulsation balloon was positioned 
per-cutaneously via a femoral artery just after the surgical draping and before 
the surgical incision. 1:1 counter-pulsation was then started (triggered upon 
arterial pressure) and maintained during graft harvesting, it was stopped 
during cardiopulmonary bypass and restarted (triggered upon pressure or 
EKG/temporary PM), for at least 24-48 hours (in absence of leg 
complications). Eventually after IABP weaning 1:2 and then 1:3, the device 
was removed per-cutaneously by manual compression and strict monitoring. 
The surgical procedures were performed via median complete 
sternotomy in all patients. Internal thoracic arteries were harvested using the 
skeletonizing technique, the radial artery was harvested with open technique 
and the saphena was harvested with open technique, skin tunnelling or endo-
surgery. Distal tract of the ascending aorta and both venae cavae separately 
were cannulated for bypass management. A left ventricular vent catheter 
through the right superior pulmonary vein and an aortic vent catheter (also 
used for cardioplegia delivery) were positioned. For the first 78 patients 
cardioplegic arrest was achieved with cold blood cardioplegia initially infused 
into the aortic root followed by retrograde infusion (through the coronary 
sinus) and then, every 20 minutes of cross-clamping time, maintained with 2 
minutes lasting only retrograde infusions. For the remaining patients, due to a 
general shift of the heart protection technique toward crystalloid cardioplegia 
in our department, a single dose of 20 ml/kg (of patient’s body weight) 
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HKT® cold antegrade cardioplegia was administered for 180 minutes of 
protection during cross-clamping. 
In order to avoid dislocation of the heart once positioned the prosthetic 
ring, marginal branches and inferior wall arteries were revascularized first. 
The indications for operation in this group of patient were the same than for 
all the other multivessel coronary patients. All branches affected by ≥ 70% 
stenosis (50% for left main) and with a good run-off demonstrated by 
angiogram (usually equivalent to a vessel diameter ≥ 1-1,5mm) were 
revascularized. Saphena was in preference used as a sequential graft in order 
to obtain the greatest run-off by performing anastomoses to 2-3 coronary 
branches. All vascular anastomoses were performed using surgical telescopes, 
with a polypropylene running suture. The revascularization of the left anterior 
descending artery (and diagonal branches) was performed after the closure of 
atriotomy using the left internal thoracic artery in all patients but one because 
previous thoracic irradiation for lymphoma with patent mammary but not-
satisfactory arterial wall. The right thoracic artery in addition to the left was 
used only in patients younger than 70years, in good clinical conditions and 
with good prognosis. The percentage of bilateral mammaries in this group of 
patients was lesser in general CAD patients because the relative higher risk. 
The use of radial artery for revascularization was motivated by: juvenile age, 
contraindications to the use of bilateral thoracic arteries, previous 
saphenectomy. Allen test, followed by Doppler examination for doubtful 
results let us discriminate contraindications to the use of the radial artery. 
Proximal anastomoses on the ascending aorta (when needed) were performed 
during cross-clamping with a polypropylene running suture. A mean of  2.6 ± 
1.2 anastomoses per patient was performed with a mean of 1.2 ±0.07 arterial 
grafts.  
The surgical approach to the mitral valve was obtained through a direct 
left atriotomy at inter-atrial groove just underneath the confluence of the 
venae cavae, or in alternative through a right atriotomy and trans-atrial 
incision. After the positioning of an atrial spreader, morphologic and 
functional analysis of the valve was done, assisted by intra-operative trans-
oesophageal echocardiography because of the complete integrity of the valve 
in this group of patients. The pathophysiologic assessment of the mitral valve 
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was done accordingly with the criteria proposed by Carpentier 2. The size of 
the ring used for the annuloplasty was chosen on the basis of 
echocardiographic measurements and direct measurements with a mitral 
obturator of the inter-trigonal distance and the length of the anterior leaflet. 
Two different types of mitral ring were used (Carpentier classic, Carpentier 
Physio [Edwards Lifesciences, Irvine, CA]). Mean diameter of the rings was 
27.6 ± 1.6 mm. Lone annuloplasty was sufficient for 69% of patients (77), and 
it was  indispensable to add secondary chordal resection in 11 (10%) and 
para-commmissural edge-to-edge suture in 17 (15%). Nine patients underwent 
circular endoventriculoplasty because of the presence of a left ventricular 
aneurysm conditioning significant left ventricular dys-synergy.  
Initial evaluation of the conservation of mitral valve symmetry and of 
the correct level of coaptation of the leaflets was achieved by ventricular 
filling with saline. Mean bypass time and cross-clamping time were 123 ± 31 
minutes and 94 ± 25 minutes respectively. Final intra-operative evaluation 
was performed with trans-oesophageal echocardiography in order to evaluate 
the presence and the degree of possible residual mitral incompetence, diastolic 
trans-mitral gradient, valve area and coaptation depth of the leaflets.  
A residual mitral jet ≤ 1 +,  a coaptation depth of 0.5  – 0.9 cm, and a 
mitral area > 2 cm2 were considered signs of good surgical repair. 
 
 31 
Statistical analysis 
 
Statistical analysis was performed using a computer software [SPSS per 
Windows (SPSS, Inc, Chicago, IL)] to search for associations between 
preoperative characteristics of the patients and early clinical events, and to 
analyse the results of the repair using the serial echocardiographic 
examinations. Measures are expressed as mean values ± DS and are compared 
with Student’s t-test for paired and unpaired data. Repeated measures have 
been compared using the ANOVA method of analysis and the post-hoc Sheffè 
method for multiple groups. It was considered statistically significant p<0.05 
and highly significant p < 0.001. The confront of proportions was performed 
using the χ² test and the Mantel Haenszel test.  
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RESULTS 
 
Surgical mortality 
  
One patient (0.9%) died for intra-operative low cardiac output not 
responding to maximal inotropic therapy and intra-aortic counter-pulsation. 
30-day mortality was 5.4% with 6 deaths of whom one for intra-operative low 
cardiac output (see above), 3 for postoperative low cardiac output syndrome, 
one for complications correlated to acute renal insufficiency (although treated 
with CVVH), and one for respiratory distress. 
 Of the 105 patients discharged, 82 have been addressed to a 
cardiological rehabilitation centre where a protocol of at least 2 weeks 
(depending on the individual health conditions) have been completed, 2 
patients have been transferred to another ICU, the rest of the patients have 
been moved to a cardiology ward to ameliorate the medical therapy.  
 One patient moved to an extra-unit ICU died after 7 weeks because of 
neurological complications while the other patient was later transferred to a 
rehabilitation unit with good functional recovery. 
 Univariate analysis for 30-day mortality showed an association with 
advanced age (73 ± 10 vs 67 ± 10 years, p = 0.05), minor ejection fraction (27 
± 7% vs 36 ± 11 %, p = 0.002), redo operation (2 redo vs 4 redo, p = 0.04), 
end-systolic left ventricular volume (89 ± 7 vs 83 ± 6 mL, p = 0.02), systolic 
pulmonary artery pressure (48 ± 11 vs 36 ± 9 mmHg, p = 0.001), preoperative 
NYHA class (3.6 ± 0.4 vs 3.1 + 0.5, p = 0.03). Gender and ERO area were not 
significantly associated. None of the parameters above resulted independent 
risk factor for 30-day mortality at multivariate analysis.   
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Specific morbidity secondary to trans-oesophageal echocardiography and 
to peri-operative prophylactic aortic counter pulsation  
All interventions were performed under TEE surveillance with probe 
insertion after the induction of anaesthesia and removal after chest closure. 
No complication was observed relative to extensive use of TEE.  
In one patient IABP was inserted (and removed) by open surgical  
technique because of contextual femoral false-aneurysm secondary to 
angiogram, in presence of contra-lateral stenotic iliac, uneventfully. Another 
patient with prophylactic IAPB showed enzymatic increase (mainly muscular) 
without critical state of the omolateral (to IABP) lower limb. In this patient it 
was preferred to remove the device with open technique, uneventfully. A 
patient with clinically indicated (not prophylactic) IABP developed severe 
ischemia of the lower limb that necessitated surgical removal, fomoro-
popliteus bypass graft, fasciotomy and continuous veno-venous hemofiltration 
to reduce the negative effects of the great enzymatic release specific of 
myonecrosis.  
   
 
Follow-up events 
Two late deaths were reported: one 12 months after the operation due to 
therapy refractory heart failure, and another 18 months after the operation due 
to a major neurologic event. Remaining patients are in fairly good clinical 
state with 94 patients in I-II NYHA class and 9 patients in III class. For 
patients in III class careful evaluation is going on for possible implantation of 
bi-ventricular pacemaker whenever possible. Because the present few late 
events no statistical analysis upon them has been performed.  
 
 
Follow-up echocardiography  
Via telephone contact with the patient or his/her practitioner, the higher 
number of early echocardiographs (1-6 months) has been collected, and 
another follow-up echocardiography at our division has been proposed. 
Nineteen patients didn’t come because excessive distance from the hospital, 
of these: 4 patients have mailed a private echocardiography and 2 have 
 34 
communicated it by phone. A total of 112 preoperative echocardiograms has 
been collected, 112 intra-operative examinations, 106 at discharge, 78 at early 
follow-up, and  90 at late follow-up.    
 
 
Residual mitral regurgitation and mitral deformation  
Trans-thoracic echocardiography at discharge (Tab. IV) pointed out 
mild residual mitral regurgitation in 4 patients (3.6%), trivial mitral 
regurgitation in 29 (25.9%), no regurgitation in the remaining 79 patients 
(70.5%).  Mean coaptation depth was 0.8 ± 0.2 cm ( p < 0.001 vs pre-
operative). Mean diastolic trans-mitral pressure gradient was 2.5 ± 0.5 mmHg 
and the mitral valve area in systole was 2.6 ± 0.7 cm², in diastole 3.3 ± 0.5 
cm².  
At early follow-up in 72 patients (68%) no residual regurgitation was 
present, in 28 (26%) regurgitation was trivial, and in 6 (6%) it was mild.  
Mean diastolic trans-mitral pressure gradient was 2.4 ± 0.3 mmHg (p = ns vs 
discharge), mean coaptation depth was 0.8 ± 0.2 cm (p = ns vs discharge), 
Mitral valve area in systole was 2.6 ± 0.4 cm² and in diastole was 3.4 ± 0.6 
cm² (p = ns vs discharge).  
Similar values were observed at later follow-up: no residual 
regurgitation in 64 cases (71%), trivial regurgitation in 22 (24%) and mild in 
4 (5%). Mean diastolic trans-mitral pressure gradient (2.3 ± 0.3mmHg), 
coaptation depth (0.8 ± 0.2cm) and mitral valve area in systole (2.6 ± 0.7cm2) 
and in diastole (3.4 ± 0.9cm2) were nearly the same of early follow-up (p = 
ns). Tenting area reduced from 3.4 ± 1.1 cm2 to 1.9 ± 0.5cm2 at discharge 
(p<0.001), and to 1.9 ± 0.5cm2 and 1.9 ± 0.3cm2 at early and late follow-up.
  
 
 
Global left ventricular remodelling 
As shown in Tab. V, mean end-systolic and end-diastolic dimensions of 
the left ventricle and the size of the left atrium reduced at discharge (p<0.001, 
p = 0.005, p = 0.002, respectively), with a further decrease at early and late 
follow-up. End-diastolic and end-systolic mean left ventricular volume 
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significantly reduced at discharge (p = 0.001 and p = 0.01, respectively) and 
at early follow-up (p = 0.004 and p = 0.02), it didn’t at later follow-up (p = 
ns). Mean left ventricular ejection fraction showed an increase at discharge (p 
< 0.001) and remained stable in later examinations. Systolic and diastolic 
sphericity index significantly reduced at discharge (p = 0.002 and p < 0.001, 
respectively) and at early follow-up (p < 0.001). No further amelioration was 
noticed at later follow-up. End-systolic wall stress significantly reduced at 
discharge (p < 0.001), at early follow-up (p < 0.001), and at late follow-up (p 
< 0.001). 
 
 
Reverse left ventricular remodelling 
Considering at least a 15% decrease of the end-systolic volume of the 
left ventricle as an index of left ventricular reverse remodelling (LVRR),  
61% of the patients (n. = 64) showed LVRR at discharge, 78% (n. = 61) at 
early follow up (χ2 = 10.1, p = 0.006) and 87.5% (n. = 79) at late follow-up 
(χ2 = 0.57, p = ns). In 11 patients (12.5 %) no reverse remodelling was 
observed. In patients with LVRR end-systolic volume reduced from 125.0 ± 
15 ml to 87.4 ± 8.1ml at late follow-up (p<0.001). In patients without LVRR, 
mean end-systolic volume was 131 ± 10 ml pre-operatively, 97 ± 9 ml 
(p<0.001) at late follow-up (p<0.001 vs. patients with LVRR). In patients 
without LVRR mean end-systolic left ventricular diameter was 52.4 ± 3.2 mm 
vs 49.6 ± 2.9 mm (p = 0.01) and end-diastolic left ventricular diameter was 
63.0 ± 2.1 mm vs 59.6 ± 3.0 mm, (p = 0.005), and left ventricle was more 
“spherical”([systolic SI 0.5 ± 0.07 vs 0.7 ± 0.04, p<0.001], [ SPI diastolic 0.7 
± 0.02 vs 0.8 ± 0.03, p = 0.006) in confront of patient with early and late 
LVRR. 
  
 
Regional left ventricular remodelling 
Regional remodelling (Tab. VI) consisted of significant posterior 
displacement of both PMs (p<0.001), significant apical displacement 
(distance between PM and contra-lateral leaflet fibrosa, p<0.001), separation 
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between PMs (p=0.001) and WMI referred to PMs (p=0.01) significantly 
reduced at discharge, not further varying at  later follow-up. Lateral 
displacement of both PMs didn’t showed significant changes however. 
 
 
Left ventricular diastolic function 
Part of the patients recovered a normal diastolic pattern at discharge 
(46%), at early follow-up (50%) and at late follow-up (54%), Tab. VII. A 
time-related decrease of the number of patients with a restrictive pattern was 
noticed (p<0.001) and, at late follow-up, only 3 patients (3%) presented such 
a pattern of diastolic filling (p<0.001 vs pre-operatively). Trans-thoracic 
echocardiography at discharge showed a significant increase of the E-wave 
(p=0.04) and a concomitant decrease both of deceleration time (p=0.006) and 
of iso-volumetric relaxation time (p=0.01). No further variations were 
observed in later follow-up. A-wave and E/A ratio didn’t vary significantly. 
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DISCUSSION 
 
Ischemic mitral regurgitation is a functional disease without structural 
alterations of the leaflets and of the chordal apparatus, it correlates with 
altered geometry and function of the left ventricle and, as a result, of the 
mitral valve. A lot of studies such as those performed by the Mayo Clinic 
echo-lab importantly aided in identification of the mechanisms causing 
ischemic mitral regurgitation 19,6. However, in spite of a better comprehension 
of these mechanisms of reduced leaflet coaptation, the outcome following 
mitral repair are not satisfactory because a recidivism rate of mitral 
regurgitation near to 30% at one year 38. On the contrary, very interesting 
outcomes are described when myocardial surgical revascularization is 
associated to undersized mitral annuloplasty, and this represents at present the 
standard treatment of patients with (chronic) ischemic mitral regurgitation. 
Undersized annuloplasty is a physiological correction that, notwithstanding 
the restoration of a good coaptation of the mitral leaflets (by reducing the 
annular diameter), it cannot address the ventricular deformation determining 
the tethering of the leaflets.  
Nonetheless, papers including heterogeneous groups of patients, let us 
completely comprehend the real efficacy of the combined CABG to 
undersized annuloplasty. Bolling et al. in 1995 29 demonstrated feasibility of 
the combined operation and then evaluated the mid-term and long-term 
survival of left ventricular wall stress via a remodelling of the base of the 
heart and via a more elliptical reshaping. 
Bax et al. 39 described a group of patients treated with the combined 
intervention in whom mitral regurgitation had been virtually always corrected 
and 2-year survival was 84%. 
 
 
Overall surgical risk 
This particular group of patients represents a population at high risk of 
intra-operative, early post-operative and late postoperative complications. 
Despite a well defined strategy oriented to minimise the complications 
 38 
secondary to postoperative low cardiac output syndrome, mortality remains 
significantly high but probably susceptible of further improvements. An 
encouraging future challenge might be represented by the clinical aid 
provided by preoperative cardiac re-synchronisation with bi-ventricular 
pacing into a wider population. In our centre we treated several patients with 
ischemic mitral regurgitation associated to ventricular dys-synchronism by 
implantation of a bi-ventricular pacemaker, optimisation of medical therapy 
and peri-operative intra-aortic counter-pulsation, so achieving encouraging 
(but not statistically significant because of number) results.  
At present the strategy chosen in our centre for the therapy of patients 
affected by more then mild chronic ischemic mitral regurgitation does not 
provide for the possibility of randomise patients to lone revascularization or to 
revascularization associated to annular procedure. We believe in fact that, on 
the basis of the present literature, this could be represent a risk of under-
treatment unjustifiable for an basically high surgical risk population. For this 
we cannot provide complete original data to confront a more conservative 
treatment with the complete one. A meta-analysis involving wider populations 
and with greater statistical power could be useful to better clarify this 
comparison.    
 
 
Recidivism of mitral regurgitation 
Hung and co-workers 16 described the relapse of mitral regurgitation in 
30 patients who underwent mitral annuloplasty for ischemic mitral 
regurgitation (4-year follow-up) and it was correlated to continual left 
ventricular remodelling and to presence of leaflet tethering. Moreover, Tahta 
et al. 38 reported 24% of mild mitral regurgitation and 5% of moderate 
regurgitation after 3 years of follow-up of a wide population of patients. In 
these patients however annuloplasty wasn’t always undersized. In a more 
recent paper McGee et al. 40 reported about 585 patients subjected to mitral 
annuloplasty plus CABG in whom 6-months recidivism of at least moderate 
mitral regurgitation was 28%.  Yet, contrarily to our group of patients, in 79% 
of cases annuloplasty had been performed using a flexible band (68%) or a 
bovine pericardial strip (11%). Bax et al 39  on the other hand reported 
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excellent results at 1,5-year follow-up in a group of 51 patients who 
underwent restrictive annuloplasty with undersized (2 sizes) ring: 34 (75.5%) 
patients without relapse of mitral regurgitation, 22.2% (n=10) trivial 
regurgitation and 2.2% (n=1) moderate regurgitation. In a more recent report, 
Geidel 41 and co-workers reported data about restrictive annuloplasty and 
CABG performed in 38 patients with ischemic mitral regurgitation: 
interestingly in this group of patients restrictive annuloplasty was performed 
in a “dynamic” fashion, that is related to left ventricular function (ring 2, 3 or 
4 in presence o ejection fraction respectively >30, 20-30%, < 20%), using 
both flexible (n=8) or semi-rigid rings (n=30). At late follow-up (13±7 
months) 5 patients (17%) had mild mitral regurgitation, 9 moderate. At 
discharge it was observed a decrease by 10% of end-diastolic diameter of the 
left ventricle in 47% of patients, and of end-systolic diameter in 86% of them.  
Our survey reports data concordant to these latter papers: relapse of 
mitral regurgitation at discharge and at early follow-up was respectively 
0.3±0.3 e 0.3±0.4. At late follow-up 71.4 % of patients didn’t showed mitral 
regurgitation at all, 24.1% had a trivial mitral regurgitation and 4.5% a mild 
one. None of the patients required a re-operation for recidivism of mitral 
regurgitation.  
 
 
Left ventricular remodelling 
A significant restraint to geometrical left ventricular remodelling 
represents an important aim of the treatment of ischemic mitral regurgitation. 
As suggested by a lot of studies upon remodelling, on the basis of Laplace’s 
law the left ventricular volume is considered as an index of the remodelling 42; 
a 15% decrease of the end-systolic volume (in confront of the basal) has been 
considered as an index of reversed remodelling. Braun et al. 43 investigated the 
possible preoperative variables predictive of reverse remodelling into a group 
of 87 patients who underwent CABG associated to restrictive annuloplasty. At 
a 18-month follow-up 60.5% (n=45) of the patients developed a significant 
reverse remodelling (giving significance to a reduction ≥ 10% of the end-
diastolic diameter). The cut-off values predictive of reversion of the 
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remodelling resulted respectively an end-systolic diameter of 41 mm and an 
end-diastolic diameter of 61 mm. In our survey, at late follow-up, a decrease 
≥ 15% of the end-systolic volume was observed in 87.5% of the patients. That 
has been considered an index of reversed left ventricular remodelling. In all 
these subjects the preoperative end-systolic and end-diastolic left ventricular 
diameters and the sphericity indexes were high. A decrease of end-diastolic 
volume and of end-systolic diameter was less frequently noticed. These 
results suggest that the reversion of the left ventricular remodelling consists of 
a gradual and time-dependent process.  
Relatively to the local remodelling, the apical displacement of the PMs 
and the WMSI of the segments supporting the PMs decreased significantly at 
discharge but didn’t showed further improvement at late follow-up. This is of 
great interest because the apical and posterior displacement of the PMs is the 
major determinant of the valvular tenting, not-dependant from the global 
remodelling of the left  ventricle 19.  
 
 
Diastolic function 
In our survey an improvement of the diastolic function was noted in 
54% of patients. In all these cases a normal trans-mitral flow pattern at late 
follow-up was demonstrated. Besides, the number of patients with a 
restrictive pattern reduced “over time” (p<0.001) and, at late follow-up, only 
3 patients presented such a pattern f atrial filling. This seems very important 
because a restrictive pattern represents an independent predictive factor of a 
worst clinical outcome, because of progression of the mitral regurgitation, and 
of negative remodelling of the left ventricle after mitral valve repair 37. 
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Limitations of the study 
 
At present our study presents the following limitations: 
• the retrospective nature;  
• the number of patients, that, despite greater (and composed by a more 
homogeneous kind of patients) in confront of other similar studies, is 
relatively small yet, reducing the force of the analysis; 
• the surgical indication for the patients in study is relatively “subjective” 
• only the surgical population of patients affected by chronic ischemic 
mitral regurgitation has been studied 
• the echocardiographic examinations have been conducted accordingly to 
clinical issues and not research issues (examination coincident with 
reading) 
• the duration of the follow up is still quite short and didn’t let us make 
conclusions upon the long term efficacy of the surgical technique used to 
treat these patients;  
• the evaluation of the reverse remodelling is based on the analysis of 
volumes obtained only with echocardiography. The echocardiographic 
estimation of the left ventricular volumes is influenced by the geometrical 
variables used for the computation.  
The new acquisitions in cardiovascular magnetic resonance allow a more 
accurate measurement of the volumes and the left ventricular function and 
mass, because they are not correlated to geometrical postulates. However, 
because the aim of this study was to compare longitudinally the changes of 
volume in the single patients and not between different groups, the effects of 
the geometrical variables in the computation of the volumes could be 
considered as negligible;  
• every patient in our study has been arbitrarily implanted with  a two-size 
under-sized ring. Perhaps a more rational approach could be to use 
different degree of under-sizing depending on the entity of tethering.  
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CONCLUSIONS 
 
Despite mentioned limitations of the study, we can conclude that in our 
experience the combined CABG with undersized mitral annuloplasty provides 
good clinical results in terms of recidivism of mitral regurgitation (at mid-
term) and of improvement of systolic and diastolic function of the left 
ventricle of patients affected by chronic ischemic mitral regurgitation. 
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APPENDIX 
 
Post-infarction ventricular remodelling: definition 
 
As “ventricular remodelling” it’s described the pathophysiologic 
process consequent to mechanical, neuro-hormonal, and genetical factors able 
to determine a structural re-arrangement of the myocardial components 
leading to a modification of size, shape and function o the ventricle. This term 
can be used to describe the physiological modifications of the heart to adapt 
itself to growth, ageing, pregnancy and physical activity (the so called 
“physiologic hypertrophy”). Despite first pronounced to identify the structural 
changes following a myocardial infarction 44 often and often “ventricular 
remodelling” has been referred to pathological conditions including the left 
ventricular overloading secondary to hypertension, valvulopathy, 
hypertrophied and dilative cardiomyopathy. The left ventricular remodelling 
involves each component of the myocardium, from myocell to connective 
tissue to coronary vessels, leading to modifications consequent to external 
factors: mechanical (ischemia and/or overload), and humoral (tyrosine, 
angiotensin II, aldosterone...). Usually the left ventricular remodelling process 
observed in valvulopathies, hypertension and ischemic heart disease is due to 
a combined action of a sum of stimuli such as ischemia, stretch secondary to 
volume or pressure overload and increase of specific hormones and 
vasopeptides. 
 
 
“Post-infarctual” remodelling: chronology of the events 
 
The ventricular remodelling following the myocardial infarction is 
different from the usual adaptive response to body growth and from the 
pathophysiologic conditions of overload. This because in post-infarct 
remodelling the first stimulus is represented by a sudden lost of contractile 
tissue. The process isn’t uniform because the myocardial structures are 
subjected (as a consequence of a variable amount of myocites) to an over-load 
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that produces (morphologically) into a combination of ventricular dilatation 
and myocardial hypertrophy  45. 
The myocardium is constituted by 3 components integrated to form a single 
functional contractile unit:  
• myocites, differentiated cells that develop tension by their shortening 
• extracellular matrix, providing a visco-elastic scaffolding able to contrast 
the mechanical stress,  constituted by type I and type III collagen fibres, 
with a function of link together the myocites and to maintain a spatial 
relationship between the myofilaments and the capillary micro-circulation 
• capillary micro-circulation 
 
From a morpho-functional view, the post-infarct remodelling can be 
arbitrarily spliced into an early phase, limited to the first 72 hours, and a late 
phase, more than 72 hours later. During the early phase the expansion of the 
infarcted zone represents a fundamental step for the comprehension of the 
modification of the ventricular architecture that characterises the left 
ventricular remodelling; in the late phase the global involvement of the left 
ventricle leads to a time-dependent dilatation, a distortion of the geometrical 
shape and of the wall hypertrophy. 
 
 
Early phase: expansion of the post-infarct area 
 
During the first hour following the myocardial necrosis, the infarcted 
area is overrun by phlogistic processes sustained by monocites-macrophages 
and neutrophils whose activation leads to cellular digestion and to formation 
of granulation tissue the resistance of which becomes greater at the increase 
of the fibrotic component, causing the post-infarct scar. This process 
represents the beginning of a diffuse reaction of the fibrous tissue that exceeds 
that associated to macroscopic healing of the infarcted zone 46. A progressive 
accumulation of fibrillar collagen is in fact observed not only into the 
infarcted zone, but also in more distant areas, with involvement of not-
infarcted zones. Into the distant zones the “reactive” fibrosis involves the peri-
vascular space of intra-myocardial arteries followed by extension to the 
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interstitial contiguous space 47. Before and during the phase of re-absorption 
of the necrotic tissue and before the thickening of the fibrous scar, the 
infarcted area appears thin and elongated. This modification has been defined 
“infarctual expansion” or “functional systolic expansion” in order to underline 
that the acute dilation and the thinning of the akinetic and dys-kinetic 
segments were not related to a new ischemic injury 48. Histology has 
demonstrated  how the reduction of the ventricular wall thickness was 
secondary not only to myonecrosis but also to slippage side-by-side of the 
fibrous-cells with consequent reduced density of these into the infarcted zone. 
This has been confirmed by clinical-instrumental studies: in fact, thanks to the 
visualisation of the left ventricle by echocardiography it was possible to 
document the modifications of the ventricular geometry resulting into an 
increase of the length (at rest) of the akinetic segments corresponding to PMs, 
not associated to re-increase of the myonecrosis lab indexes 49. This 
mechanism of infarct expansion is considered the principal determinant of the 
ventricular dilatation during the early post-infarctual phase, that causes the 
increase of the end-systolic volume following the acute event, and that 
correlates to the functional  late evolution expressed by ejection fraction 50. 
Nevertheless this phenomenon is not systematically present after every 
infarction; in fact it’s more frequent after the trans-mural infarction that 
involve the antero-apical region rather then the remaining myocardial 
portions. The apical zone of the left ventricle is anatomically that with the 
minor thickness and with the greatest radius of bending, and so it’s an area 
particularly prone to the expansion; in fact accordingly with the La Place’s 
law, by which the wall stress is directly proportional to the pressure and the 
radius of bending and inversely proportional to the wall thickness, the 
necrosis of the ventricular apex secondary to the occlusion of the left anterior 
descending artery, leads to an increase of the radius of bending of this 
segment with consequent increase of the ventricular wall stress and tendency 
to aneurysmal dilation 51. This early event is basic for another mechanical 
complication of myocardial infarction that is the rupture of the free wall 52. 
Repercussions are also upon the not-infarcted areas, the so-called “remote 
zones”; as observed by experimental studies, during the phase immediately 
following the lost of contractile tissue, at the level of the remote zone there’s a 
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progressive increase of the end-diastolic length of the healthy myocells, 
initially associated to a greater shortening of the fibres 53. A lot of studies 
based on echocardiographic evaluation, evidenced the contemporary presence 
of the expansion of the infarcted area with the dilation of the healthy segments 
54
. These morpho-functional modifications represent the anticipation of the 
process that will later end into the model of eccentric-type ventricular 
hypertrophy secondary to a volume overload.  
 
 
Late phase: ventricular dilation and adapting mechanism 
 
As a first consequence of the ischemic event we have the lost of the 
systolic function and the systolic elongation of the infarcted segment, 
decrease of the global left ventricular function, decrease of the systolic output 
and increase of the end-systolic volume. 
The decrease of the cardiac output leads to activation of the renin-
angiotensin-aldosteron system (RAAS) via stimulation of the mechanoceptors 
of the iuxta-glomarular apparatus of the macula densa, of the adrenergic 
system (cardiac and systemic), and of the inflammatory response supported by 
hormonal factors (RAAS itself, adrenergic system, endothelins, natriuretic 
peptides, citokines, etc.), whose morphological effects will completely be 
expressed during the late phase of the ventricular remodelling. The decrease 
of the left ventricular function starts up compensatory mechanisms devoted to 
maintain a good stroke volume, such as the Frank-Starling’s force-length 
relation, exploiting the increase of the pre-load with excessive increase of the 
diastolic wall stress of the healthy myocardium, and the increase of the heart 
rate (force-rate relation), secondary to the activation of cardiac and systemic 
sympathetic nervous system. These mechanisms however are not sufficient to 
support an adequate stroke volume in presence of a > 20% lost of contractile 
tissue 55 and it was observed that the left ventricular dilation can initially 
maintain a good cardiac output in spite of the presence of a depressed ejection 
fraction 56. The increase of the size of the left ventricle however, because of 
the Laplace’s law, leads to an increase of the systolic and diastolic ventricular 
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wall stress, with further left ventricular dilation. A vicious circle starts able to 
lead to a progressive increase of the end-systolic left ventricular diameter 57. 
The extension of the post-infarctual dilation of the left ventricle deepens 
on the size of the myocardial damage and represents a prognostic factor for 
cardiac failure because of progressive time-dependent reduction of the left 
ventricular function, correlated with a decreased survival 50. 
 
   
Remodelling and cardiac hypertrophy 
 
Together with the ventricular dilation, the other mechanism of 
adaptation to the increased ventricular load is represented by hypertrophy of 
the vital portions of the left ventricle. This contributes to create an inotropic 
support to front the decreased cardiac function and is accountable for the 
hemodynamic improvement that can be noticed through the months that 
follow an infarction. 
The mechanical stimulus, as overloaded work of the normo-kinetic 
segments, represents a powerful trigger to prime a cascade of local and 
systemic events leading to hypertrophy of the healthy segments. At first 
hypertrophy represents a mechanism of functional compensation, useful to 
normalise the ventricular wall stress and to restore the ventricular function. 
The duration of the restoration is however limited in time because of the 
inborn germ of cardiac failure. In fact, also during the phase of “adequate” 
hypertrophy, molecular and humoral mechanisms ar activated that will lead to 
lost of myocites as a consequence of fibrosis.    
Myocardial hypertrophy can be defined as “the increase of the mass of 
the single myocites structurally supported by an increased protein synthesis as 
a reissue of a foetal genic program that leads to the “hypertrophic phenotype”. 
Together to myocite hypertrophy we have an expansion of the extracellular 
matrix” 58,59. Into the hypertrophic myocites we can observe the genic re-
expression of transcriptional factors, of contractile proteins (foetal iso-forms 
of myosin) and of cyto-skeleton and a reduction of superficial expression of 
β-adrenergic receptors. At tissue level we can notice an increased production 
of enzymes (ACE, βARK) and growth factors (endothelin 1, angiotensin II,  
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fibroblast growth factor 1, fibroblast growth factor 2, platelet derived growth 
factor, insulin growth factor, transforming growth factor-β1, nor-epinephrine) 
60
. 
It has been demonstrated in an in vivo model how the sole mechanical 
stimulation is capable to produce myocardial hypertrophy. However this 
would be a less “solid” hypertrophy than that sustained by growth factors, 
selectively produced by pressure or volume overload 59. What the real role of 
these growth factors is not well known yet, equally the timing of their initial 
action and the reciprocal following one another is at present in study. 
Angiotensin II seems to act as an positive inotropic agent for well contractile 
ventricles, while its action seems to be negative both in systole and in diastole 
in presence of dilated ventricles with reduced global kinetics.  
Myocites produce growth factors till hypertrophy is adequate; then, 
when the myocitary mass is not able to maintain the end-systolic wall stress 
around mid-normal values, myocites loose the synthetic phenotype and 
growth factors begin to be produced from fibroblasts and endothelial cells. In 
this phase there’s an excessive production of angiotensin II as a result of the 
synthesis from not-myocitary cells and of a up-regulated gene expression of 
angiotensinogen by tissutal RAAS, and this causes the stimulation of the 
fibroblasts with induced production of collagen 61. 
 
   
Ventricular remodelling and myocardial fibrosis 
 
The forming of fibrotic tissue is a basic process to preserve the 
structural integrity of the infarcted myocardium, however its presence 
becomes the mechanisms by which ventricular dysfunction of patients with 
previous myocardial infarction happens. 
We can recognise 2 different types of fibrosis of the ischemic myocardium: 
- “repairing type” or microscopic scar, represented by the myocardial necrosis 
and,   
- “reactive type”, expressed as peri-vascular/interstitial fibrosis, present into 
the remote zones and constituting about 2/3 of the whole cardiac fibrous 
tissue. 
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In vitro studies documented the role of the neuro-hormonal response and of 
the inflammatory response characterised by the production of TNF-α, to 
induce myocardial fibrosis; it’s been really reported an increased activity of 
ACE as an index of a greater production of angiotensin II in those myocardial 
regions where there’s a greater fibrosis (i.e. ventricular aneurysms) 62, and this 
would be reported in segments far off the infarcted area (i.e. right ventricle) 
47,61
.  
The presence of fibrous tissue into the remote zones is considered to be 
“the main cause of ventricular remodelling for patients with post-infarction 
ischemic cardiomyopathy” 46; initially this presence implies a decreased 
ventricular compliance with altered diastolic function and subsequent 
progressive tear of the systolic function. After the infarction in fact, during a 
variable period of time there’s a high turn-over of collagen, sustained by 
production from fibroblasts and by digestion from proteolytic enzymes 
(matrix metal-proteinase, MMPs) resulting into a stable balance; afterwards 
this balance shifts toward the production of extracellular matrix and the extra 
collagen “strangles” the micro-circulation of healthy myocardial segments 
provoking ischemic damage to myocites and further fibrogenesis. Therefore 
into a remodelled ventricle we can notice the simultaneous presence of a 
cicatricial area consequent to the infarction (inclined to dilation) and of an 
eccentric-type hypertrophy generated as an inotropic support but 
progressively complicated by reduction of the contractile function because of 
excessive growth of fibrosis and lost of myocites; such a lost is not dependent 
from a further infarction but from ischemic suffering of micro-circulation 
caused by fibrosis and apoptosis, mainly induced by the same growth factors. 
  
   
Ventricular dilation and modification of the ventricular geometry 
 
It’s quite intuitive how the progressive dilation of the left ventricle leads 
to an alteration of the structural geometry of the chamber itself, with a final 
result of a lost of the ellipsoidal shape and the remodelling toward a more and 
more spherical shape. Sphericity causes an increase of the radius of bending 
and of the end-diastolic volume; these structural modifications importantly 
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reverberate on the left ventricular function. This is due to an increased 
ventricular wall stress no more balanced by adaptive mechanisms previously 
set up. As a consequence of the spherical shape a series of geometrical 
variations realises not only into the myocardium but also into the anatomic 
structures connected to the left ventricle; we have a misalignment of the 
papillary muscles with a displacement of their base toward a postero-lateral 
and an apical position, a mitral annular dilation and a reduction of the 
physiologic flexibility of movement of the mitral leaflets. 
All together these modifications lead to a shift of the coaptation depth 
toward the apex of the left ventricle, far away from the annular plane and 
from the coaptation line, causing the principal alteration accountable for the 
onset of a  functional mitral regurgitation.   
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Therapeutic options directed to limit or to arrest the ventricular 
remodelling process 
 
 
The most important causes of the ventricular remodelling are the size of 
the infarcted area, preload and afterload, patency of the culprit artery; an 
increase of the endoventricular pressure increases the ventricular wall stress 
and the risk of extension of the infarcted area, on the contrary, the patency of 
the artery hastens the post-infarctual healing, reduces the lost of substance and 
the entity of ventricular dilation. 
The study of the pathophysiologic mechanisms that lead to  the post-
infarctual ventricular remodelling let us hypothesise different therapeutic 
options able to stop and possibly to reverse such a process. A lot of paper has 
demonstrated how the reperfusion of the accountable artery within 6 hours 
from the infarction, computed from the beginning of the chest pain, through 
thrombolysis or primary angioplasty reduced the size of mocardial necrosis, 
prevented transmurality, bounded the increase ov the ventricular volume and 
of the ventricular dilation 63,64. In a group of pazient in whom the infarction 
was not treated with revascularization it has been demostrated that the patency 
of the culprit artery (not the diameter) represents the most important 
predictive factor for modification of the ventricular volume during a time 
period between 48 hours ad a month after the ischemic event 65.  Postmortem 
studies suggested that the presence of “contraction band” necrosis  
(characterised by the presence of necrotic myocites with vital stroma and 
micro-circulation) into the myocardial infarctions subjected to reperfusion 
therapy, could provide a greater resistance to stretching and a minor 
propensity to expansion and confirmed the association between expansion of 
the infarcted zone and the size of the trans-mural infarction 66. Moreover the 
expansion of the necrotic area is more frequent in infarctions cause by the 
occlusion of the left anterior descending artery in confront of those caused by 
occlusion of the right coronary and is influences by the regional differences of 
wall thickness, radius of bending and trans-mural tension. 
In a recent study, Destro et al. 67, by use of the contrast-
echocardiography in patients who underwent primary angioplasty for 
myocardial infarction reported a possible effect upon the ventricular 
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remodelling induced by myocardial damage and coronary micro-circulation. 
This study demonstrates also that despite the restoration of the patency of the 
culprit artery, myocardial zones included into the area of necrosis could show 
absence of reperfusion, evaluated by means of different levels of video-
intensity, because of the “no-reflow” phenomenon, expression of the damage 
of the micro-circulation. This  has been related to the increased ventricular 
volume, the reduced ejection fraction and the reduced survival, assuming that 
the entity of myocardial reperfusion, correlated to the integrity of the micro-
circulation, could be a key-point to foretell the post-infarct variations of the 
regional kinetics and of the ventricular volume characterising the process of 
remodelling. Further clearness upon the morphological modifications of the 
post-infarctual remodelling rises from the use of diagnostic techniques more 
and more sophisticated like cardiac magnetic resonance. 
Some authors reported that during the phase immediately following the 
myocardial infarction there’s an increase of the mass of the left ventricle that 
begins to reduce after a period of about 3 months for several months. At one-
year control it’s been documented the presence o a slight increase of the 
myocardial mass in confront of the basal conditions, in absence of thickening 
of the not-infarcted myocardial wall and usually without thinning of the 
necrotic zones (peculiarity of the patients affected by large anterior 
infarction). Thanks to the analysis of the variation of signals by magnetic 
resonance it has been possible to demonstrate that the increase of he 
ventricular mass during the early post-infarctual phase is attributable to the 
presence of interstitial oedema of the ventricular wall and not to a 
compensatory hypertrophy of the residual myocardium. From this transpires 
that the parietal hypertrophy of the normo-kinetic segments is a late event in 
the entire process of remodelling and it’s of minor importance respect to the 
development of left ventricular dilation; in fact, studying the time related 
variations of the left ventricular mass/volume ratio, we can note how these 
two parameters have not parallel variations. The changes of the ventricular 
mass and the following regional thickening are greater during the early phase 
and afterwards decline because of the disappearance of the interstitial oedema 
and slightly increase when myocardial hypertrophy starts; end-systolic and 
end-diastolic volumes instead increase significantly and continuously. 
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Prognostic value of remodelling 
 
The clinical interest in these years about the ventricular remodelling is 
correlated to its evolutive character conditioning the prognosis of the infarcted 
patient. The sizes of the left ventricle, both in diastole and in systole, in the 
post-infarction period represent a powerful predictive index of late survival 68. 
“Remodelled” ventricles risk in fact a greater incidence of arrhythmic events 
and above all, hold it up the clinical and pathological scenario of heart failure. 
The demonstrated activation of neuro-hormonal systems in patients with left 
ventricular dysfunction let cardiologists to more deeply comprehend the 
causes of the pathophysiological changes of cardiac failure and to theorise 
therapeutic strategies able to cancel the effects and to improve both prognosis 
and quality of life of the patient. Sympathetic hyper-activity, for instance, 
determines on the myocardium a down-regulation and a de-sensibilization of 
β-adrenergic receptors that could reduce the cardiac response to sympathetic 
stimulation with a consequent negative inotropic and chronotropic effect, 
accountable for the appearance of fatigue and functional limitation of the 
patients. 
Besides, being the receptorial down-regulation dys-homogeneous on the 
cellular surface, it could generate spatial and temporal heterogeneity of the 
ventricular repolarization with a consequent facilitation of re-entry ventricular 
arrhythmias. 
These well supported observations confirm the favourable effect of 
therapy with β-blockers upon myocardial function and upon reduction of 
mortality both post-infarctual and in general heart failure (Capricorn study, 
Copernicus, CIBIS II e Merit-HF). It’s well known the propitious role of 
ACE-inhibitors and of anti-aldosterone in patients affected by heart failure 
(SAVE study and SOLVD, Rales study). The pharmacological therapy 
directed to reduce the ventricular wall stress possess than a favourable effect 
upon the reduction of the left ventricular remodelling, improves the systolic 
performance and reduce mortality in patients with heart failure both ischemic 
and not-ischemic.  
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Tab. I: Pathophysiologic triad of ischemic mitral regurgitation 
 
Dysfunction Lesions Acute/Chronic 
Type I Annular dilation Chronic 
Type II Rupture of papillary muscle Acute 
 Rupture of chordae Acute 
 Lengthening of PM Chronic 
Type IIIb Displacement of PM Acute/Chronic 
 Leaflet tethering Chronic 
 
Filsoufi et al. The Mount Sinai J. Med.2005 
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Tab. II: qualitative and quantitative parameters useful for gradation of mitral regurgitation. 
 Mild Moderate  Severe 
Structural parameters 
• LA diameter 
• LV diameter 
• Leaflets and/or    sub-
valvular app. 
 
Normal 
Normal 
Normal or anomalous 
 
Normal or increased 
Normal or increased 
Normal or anomalous 
 
Usually increased 
Usually increased 
Flail, rupture PM 
Doppler parameters  
• Jet area 
 
• Trans-mitral flow (PW) 
 
• Jet density (CW) 
• Jet contour (CW) 
pulmonary vein flow 
 
Small central jet, <4 
cm² or  < 20% LA area 
Dominant A-wave 
 
Mild 
Parabolic 
 
 
Variable 
 
Variable 
 
Dense 
Usually parabolic 
 
Wide central jet, >10 
cm² or > 40% LA area 
Dominant E-wave (v E 
≥1.2 m/sec) 
Dense 
Early peak, triangular 
Quantitative parameters 
Vena contracta (cm) 
RV (ml / beat) 
RF (%) 
ERO area (cm²) 
 
<0.3 
<30 
<30 
< 0.20 
 
0.3 - 0.69 
30-44                 45-59 
30-39                 40-49 
0.20-0.29      0.3-0.39 
 
≥ 0.7 
≥ 60 
≥ 50 
≥ 0.40 
 
LA = left atrium; LV = left ventricle; PM = papillary muscle; PW = pulsed wave; CW = 
continuous wave; RV = regurgitant volume; RF = regurgitant fraction; ERO = effective 
regurgitant orifice.  
 
Zoghbi WA, Enriquez-Sarano et al. Adapted from ASE/ESC Guidelines 2003, Eur J. 
Echocardiography 
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Tab. III: Preoperative characteristics 
Age (years) 67.7±8.6 
Gender M/F 72/50 (60%/40%) 
NYHA class 
Mean ±SD 
≤II 
III 
IV 
 
3.1±0.6 
16 (14.3%) 
68 (60.7%) 
28 (25.0%) 
CCS angina class 
Mean ±SD 
≤2 
≥3 
 
2.4±08 
72 (64.2%) 
50 (35.8%) 
EuroSCORE 
Standard (additive) 
Logistic 
 
8.6±3.5 
15.1±10.2% 
Cigarette smoking 35 (31.2%) 
Hypertension 45 (40.1%) 
Diabetes 29 (25.8%) 
Treated COPD 11 (9.8%) 
CRF 16 (14.2%) 
Cerebral vasculopathy 12 (10.7%) 
Peripheral vasculopathy 7 (6.2%) 
Family history of CAD 47 (41.9%) 
Myocardial infarction 
> 3 months 
                  ≤3 months 
Inferior/posterior 
Anterior/septal 
Lateral 
Combined 
 
89 (79.4%) 
23 (20.6%) 
53 (47.3%) 
9 (8.0%) 
21 (18.8%) 
29 (25.9%) 
Number of diseased vessels  
Mean ± SD 
1 
2 
3 
Left main disease 
 
2.5.±0.5 
7 (6.2%) 
30 (26.8%) 
75 (8.0%) 
16 (14.2%) 
Degree of mitral regurgitation: 
2+ 
3+ 
4+ 
 
13 (11.6%) 
68 (60.7%) 
31 (27.7%) 
Jet direction: 
Central 
Anterior 
Posterior 
Complex  
 
40 (35.7%) 
8 (7.2%) 
30 (26.8%) 
34 (30.3%) 
Continuous variables are expressed as mean value ± 1 standard deviation (SD); 
discrete variable are presented as percentage values.  
M/F= Males/Females; NYHA = New York Heart Association; CCS = Canadian 
Cardiovascular Society; COPD = chronic obstructive pulmonary disease; CRF = 
chronic renal failure; CAD = coronary artery disease. 
 
 
 68 
Tab. IV: mitral valve analysis 
Parameter Pre-op Discharge  Early f-up Late f-up P 
 
MR 
TA
 
ERO 
RF 
RV 
CH 
MAs 
MAd 
M∆p 
 
3.16±0.6 
3.4±1.1 
32± 10 
40 ± 9 
55 ±11 
1.2±0.2 
4.1 ±1.3 
5.1 ±1.2 
- 
 
0.33 ± 0.3† 
1.9±0.5† 
- 
- 
-
 
0.8±0.2† 
2.6±0.7† 
3.3±0.5† 
2.5±0.5 
 
0.38±0.4 
1.9±0.5 
- 
- 
- 
0.8±0.2 
2.6±0.4 
3.4±0.6 
2.4±0.3 
 
0.34±0.6 
1.9±0.3 
- 
- 
- 
0.8±0.2 
2.6±0.7 
3.4±0.9 
2.3±0.3 
 
<0.001 
<0.001 
- 
- 
- 
0.02 
<0.001 
  0.001 
ns 
†‡§
 significant vs. preoperatively, discharge and early follow up, respectively  
 
MR = mitral regurgitation (1-4+); TA = Tenting area (cm2); ERO = effective 
regurgitant orifice (mm2); RF = regurgitant fraction (%); RV = regurgitant (mL); CH = 
Coaptation height (cm); MAs = systolic mitral annular area (cm2); MAd = diastolic 
mitral annular area (cm2);  M∆p = diastolic trans-mitral pressure gradient (mmHg) ; ns 
= not significant. 
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Tab. V: Global remodelling of the left ventricle 
Parameter Pre-op. Discharge Early f-up Late f-up P 
 
EDD 
ESD 
LA 
ESV 
EDV 
LVEF 
Systolic SPI 
Diastolic SPI 
ESWS 
 
62±6 
51±7 
49±6 
129±22 
196±32 
33±8 
0.61±0.1 
0.74±0.1 
270±70 
 
57±7† 
46±6† 
42±3† 
116±15† 
176±27† 
40±10† 
0.42±0.1† 
0.55±0.1† 
244±51† 
 
57±8 
45±6 
42±2 
99±16‡ 
154±26‡ 
43±8 
0.34±0.1‡ 
0.44±0.1‡ 
215±33‡ 
 
56±6 
44±5 
42±2 
94±16 
152±20 
44±6 
0.34±0.1 
0.44±0.1 
189±35§ 
 
0.001 
<0.001 
<0.001 
<0.001 
<0.001 
ns 
<0.001 
<0.001 
<0.001 
 
†‡§
 significant vs. preoperatively, discharge and early follow up, respectively.  
 
EDD = end-diastolic diameter (mm); ESD = end-systolic diameter(mm); LA = 
left atrium (mm); ESV = end-systolic (left ventricular) volume (ml); EDV = 
end-diastolic (left ventricular) volume (ml); LVEF = left ventricular ejection 
fraction (%); SPI = sphericity index; ESWS = end-systolic (left ventricular) 
wall stress (g/cm2 ); ns =  not significant. 
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Tab. VI: Local remodelling of the left ventricle 
Parameter Pre-op.  Discharge Early f-up Late f-up p 
 
PPM posterior D  
APM posterior D 
PPM lateral D 
APM lateral D 
PPM-fibrosa D 
PMs separation 
PPM WMI 
APM WMI 
 
2.6±0.6 
2.9±0.5 
1.9 ±0.4 
1.3±0.3 
6.9±0.6 
3.6±0.5 
2.1±0.7 
1.9±0.4 
 
2.0±0.5† 
2.2±0.2† 
1.8±0.3 
1.2±0.2† 
5.8±0.4† 
3.1±0.2† 
1.6±0.2† 
1.3±0.1† 
 
2.1±0.3 
2.2±0.3 
1.8±0.3 
1.2±0.3 
5.8±0.4 
3.0±0.2 
1.5±0.2 
1.2±0.1 
 
2.1±0.3 
2.2±0.3 
1.8±0.3 
1.2±0.3 
5.8±0.4 
 3.1±0.2 
1.5±0.2 
1.2±0.1 
 
0.01 
0.01 
ns 
ns 
<0.001 
<0.001 
0.005 
0.002 
 
†‡§
 significant vs. preoperatively, discharge and early follow up, respectively.  
 
PPM = posterior papillary muscle; D = distance (cm); APM = anterior papillary 
muscle; PMs = papillary muscles; WMI = Wall motion index; ns = not significant. 
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Tab. VII: Diastolic function 
Parameter Preop.  Discharge Early f-up Late f-up P 
 
E 
A 
E/A  
DT 
IVRT 
Normal diastolic   
pattern 
Altered relax. 
Pseudo-normal 
Restrictive 
 
 
64.4±12 
55.1±14 
1.3 ±0.6 
215.6±30 
90±10 
 
3 ( 2.7 %) 
48 (42.8%) 
18 (16.1 %) 
43(38.4 %) 
 
71.4±15† 
56.7±10 
1.2±0.3 
190±26† 
70±7 † 
 
52 (46.4%)† 
40 (35.7%) 
15 (13.4%) 
5 ( 4.5%)† 
 
71.8±12 
56.2±7 
1.2±0.32 
192±31 
73.1±7 
 
56 (50.0%) 
39 (34.8%) 
14 (12.5%) 
3   (2.7%) 
 
71.1±12 
56.4±6 
1.2±0.3 
195.1±17.3 
74.0±6 
 
60 (53.6%) 
37 (33.0%) 
12 (10.7%)§ 
3 (2.7%) 
 
 
0.001 
ns 
ns 
<0.001 
<0.001 
 
<0.001 
ns 
ns 
<0.001 
 
†‡§
 significant vs. preoperatively, discharge and early follow up respectively.  
 
E = trans-mitral flow peak velocity;  A = late trans-mitral flow peak velocity; DT = 
deceleration time of the early filling (ms); IVRT = isovolumetric relaxation time (ms); ns 
= not significant.  
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FIGURES 
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Fig. 2: 5-year survival of patients affected by myocardial infarction with or 
without mitral regurgitation 
Grigioni et al. Circulation 2001
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Fig. 3: anterior and posterior mitral leaflets, subdivided in P1, P2, P3 and A1, 
A2 and A3 respectively. AC = anterior commissure, PC = postero-medial 
commissure. 
Filsoufi et al. The Mount Sinai J. Med.2005 
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Fig. 4 : Displacement of the papillary muscle. 
Shengqiu et al. Circulation 1997 
 77 
 
 
 
Fig. 5: Displacement of postero-medial papillary muscle, longitudinal view 
Levine R., NEJM 2004 
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Fig. 6 : PM displacement and tethering forces 
Otsuji et al. Circulation 1997 
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Fig. 7 : Effective regurgitant orifice in ischemic mitral regurgitation : for 
details see text . 
Shengqiu et al. Circulation 1997 
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Fig. 8 : A = Pathophysiology of chronic ischemic mitral regurgitation ; B = tented area 
under leaflets 
Shengqiu et al. Circulation 1997 
A 
B 
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Fig. 9 : left ventricular diameters and ischemic mitral 
regurgitation : for details see text. 
Otsuji et al. JACC 2002 
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